Board Meeting7 Aug 2026, 02:01 pm
Emmessar Biotech Declares Unaudited Q1 FY27 Results
AI Summary
Emmessar Biotech & Nutrition Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved these results on August 7, 2026. A limited review report from statutory auditors M/s. V. Nagarajan & Co. was also provided. The company also announced its 34th Annual General Meeting (AGM) will be held on September 29, 2025, through video conferencing, with a cut-off date of September 22, 2026, for remote e-voting. The remote e-voting period is scheduled from September 26 to September 28, 2026.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Board approved results on August 7, 2026.
- Limited review report from statutory auditors enclosed.
- 34th AGM scheduled for September 29, 2025, via video conference.
- Remote e-voting period set for September 26-28, 2026.
Price Impact
More from EMMESSA